Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.

Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey R, Manaves V, Shaw B, Algire M, Hessler P, Lam LT, Uziel T, Faivre E, Ferguson D, Buchanan FG, Martin RL, Torrent M, Chiang GG, Karukurichi K, Langston JW, Weinert BT, Choudhary C, de Vries P, Kluge AF, Patane MA, Van Drie JH, Wang C, McElligott D, Kesicki EA, Marmorstein R, Sun C, Cole PA, Rosenberg SH, Michaelides MR, Lai A, Bromberg KD.

Nature. 2018 Jun;558(7710):E1. doi: 10.1038/s41586-018-0111-5.

PMID:
29769713
2.

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.

Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey R, Manaves V, Shaw B, Algire M, Hessler P, Lam LT, Uziel T, Faivre E, Ferguson D, Buchanan FG, Martin RL, Torrent M, Chiang GG, Karukurichi K, Langston JW, Weinert BT, Choudhary C, de Vries P, Van Drie JH, McElligott D, Kesicki E, Marmorstein R, Sun C, Cole PA, Rosenberg SH, Michaelides MR, Lai A, Bromberg KD.

Nature. 2017 Oct 5;550(7674):128-132. doi: 10.1038/nature24028. Epub 2017 Sep 27. Erratum in: Nature. 2018 May 16;:.

3.

The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors.

Boghaert ER, Lu X, Hessler PE, McGonigal TP, Oleksijew A, Mitten MJ, Foster-Duke K, Hickson JA, Santo VE, Brito C, Uziel T, Vaidya KS.

Neoplasia. 2017 Sep;19(9):695-706. doi: 10.1016/j.neo.2017.06.004. Epub 2017 Aug 5.

4.

Potential mechanisms of resistance to venetoclax and strategies to circumvent it.

Tahir SK, Smith ML, Hessler P, Rapp LR, Idler KB, Park CH, Leverson JD, Lam LT.

BMC Cancer. 2017 Jun 2;17(1):399. doi: 10.1186/s12885-017-3383-5.

5.

HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues.

Lin X, Huang X, Uziel T, Hessler P, Albert DH, Roberts-Rapp LA, McDaniel KF, Kati WM, Shen Y.

Mol Cancer Ther. 2017 Feb;16(2):388-396. doi: 10.1158/1535-7163.MCT-16-0475. Epub 2016 Nov 30.

6.

Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075.

Faivre EJ, Wilcox D, Lin X, Hessler P, Torrent M, He W, Uziel T, Albert DH, McDaniel K, Kati W, Shen Y.

Mol Cancer Res. 2017 Jan;15(1):35-44. doi: 10.1158/1541-7786.MCR-16-0221. Epub 2016 Oct 5.

7.

Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.

Zhang H, Xue J, Hessler P, Tahir SK, Chen J, Jin S, Souers AJ, Leverson JD, Lam LT.

Mol Cancer. 2015 Jul 2;14:126. doi: 10.1186/s12943-015-0397-y.

8.

MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor.

Xiao Y, Nimmer P, Sheppard GS, Bruncko M, Hessler P, Lu X, Roberts-Rapp L, Pappano WN, Elmore SW, Souers AJ, Leverson JD, Phillips DC.

Mol Cancer Ther. 2015 Aug;14(8):1837-47. doi: 10.1158/1535-7163.MCT-14-0928. Epub 2015 May 26.

9.

Q&A: Peter Hessler on urbanization in China. Interview by Jane Qiu.

Hessler P.

Nature. 2010 Mar 11;464(7286):166. doi: 10.1038/464166a. No abstract available.

PMID:
20220825
10.

Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines.

Tahir SK, Wass J, Joseph MK, Devanarayan V, Hessler P, Zhang H, Elmore SW, Kroeger PE, Tse C, Rosenberg SH, Anderson MG.

Mol Cancer Ther. 2010 Mar;9(3):545-57. doi: 10.1158/1535-7163.MCT-09-0651. Epub 2010 Feb 23.

11.

Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.

Liu X, Shi Y, Woods KW, Hessler P, Kroeger P, Wilsbacher J, Wang J, Wang JY, Li C, Li Q, Rosenberg SH, Giranda VL, Luo Y.

Neoplasia. 2008 Aug;10(8):828-37.

12.

[A rare cause of cauda equina syndrome: primary epidural lymphoma].

Bachmeyer C, Kazerouni F, Langman B, Daumas L, Hessler P.

Presse Med. 2005 Sep 10;34(15):1082-3. French.

PMID:
16334886
13.

Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line.

Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler P, Kroeger PE, White DW, Jirousek MR, Trevillyan JM.

Mol Cell Endocrinol. 2002 Sep 30;195(1-2):109-18.

PMID:
12354677
14.

Genome scanning in Haemophilus influenzae for identification of essential genes.

Reich KA, Chovan L, Hessler P.

J Bacteriol. 1999 Aug;181(16):4961-8.

15.

Isolation of isoflavones from soy-based fermentations of the erythromycin-producing bacterium Saccharopolyspora erythraea.

Hessler PE, Larsen PE, Constantinou AI, Schram KH, Weber JM.

Appl Microbiol Biotechnol. 1997 Apr;47(4):398-404.

PMID:
9163954
16.

Separation of left and right skull bones from low angle x-ray projections.

Fröder M, Hessler P, Weiss T.

Phys Med Biol. 1990 Jun;35(6):703-15.

PMID:
2195559
17.
19.

Recurrent pacemaker electrode displacement into the right atrium with capture.

Pagonis CP, Hessler PC.

R I Med J. 1982 Jan;65(1):37-9. No abstract available.

PMID:
6459637
20.

High accuracy sonographic recognition of gallstones.

Hessler PC, Hill DS, Deforie FM, Rocco AF.

AJR Am J Roentgenol. 1981 Mar;136(3):517-20.

PMID:
6781288
21.

Renal adenocarcinoma in an asymptomatic 19-year-old female.

Hessler PC, Hill DS, Siddiqi N.

Urol Radiol. 1981;3(2):117-20.

PMID:
7314322
22.

Adenocarcinoma of the duodenum arising in a villous adenoma.

Hessler PC, Braunstein E.

Gastrointest Radiol. 1978 Feb 23;2(4):355-7.

PMID:
669157

Supplemental Content

Loading ...
Support Center